Valhalla Tech

Overview

Scientific intelligence company developing molecular world models and AI drug development platforms

USD estimates from the source record

Listed 3 funding records. Latest funding: $46M (股权投资), Jul 28, 2026.

Annual trendUnit: USD estimate

Date	Amount	Investors	Source
Jul 28, 2026	$46M	Guangyuan L2F Fund, Hangzhou Xiangfeng Venture Capital Partnership (Limited Partnership), Jiaxingzhengeruiyuanguquan Investment Partnership (Limited Partnership), Qijichuangtan, Shanghai Guofang Innovation Private Fund Partnership (Limited Partnership), Suzhou Xinghengweilairencai Venture Capital Partnership (Limited Partnership), Tianjin Lushihangsheng Venture Capital Zhongxin (Limited Partnership), Wuyuan Capital
Jul 28, 2026	$50M	Guangyuan L2F Fund, Guofang Venture Capital, Lushi Investment, Qijichuangtan, Wuyuan Capital, Xianghe Capital, Zhenge Fund, Zhongkechuangxing	Source ↗
Jun 9, 2026	$4.3M	Beijing Qijichuangtan Phase Two Venture Capital Zhongxin (Limited Partnership), Woyi Phase Three Co., Ltd.

USD estimates from the source record

Listed 3 valuation records.

Annual trendUnit: USD estimate

No chartable valuation estimates yet.

3 listed records lack a clear date or positive USD estimate for the chart.

Date	Amount	Investors	Source
Jul 28, 2026	—	Guangyuan L2F Fund, Hangzhou Xiangfeng Venture Capital Partnership (Limited Partnership), Jiaxingzhengeruiyuanguquan Investment Partnership (Limited Partnership), Qijichuangtan, Shanghai Guofang Innovation Private Fund Partnership (Limited Partnership), Suzhou Xinghengweilairencai Venture Capital Partnership (Limited Partnership), Tianjin Lushihangsheng Venture Capital Zhongxin (Limited Partnership), Wuyuan Capital
Jul 28, 2026	—	Guangyuan L2F Fund, Guofang Venture Capital, Lushi Investment, Qijichuangtan, Wuyuan Capital, Xianghe Capital, Zhenge Fund, Zhongkechuangxing	Source ↗
Jun 9, 2026	—	Beijing Qijichuangtan Phase Two Venture Capital Zhongxin (Limited Partnership), Woyi Phase Three Co., Ltd.

USD estimates from the source record

No revenue records are listed yet.

Annual trendUnit: USD estimate

No chartable revenue estimates yet.

No revenue rows to list.

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

研发分子世界模型与AI药物研发平台的科学智能公司